How Can Oncology Trials Be Decentralized?

How Can Oncology Trials Be Decentralized?

October 27, 2021PAO-10-21-CL-16

On this episode of the PPD® podcast Oncology Imperatives, Dr. Dave Frakes, Vice President and Global Medical Officer for PPD Biotech, is joined by Simon Coggins, Vice President and Digital Solutions Lead for PPD’s hematology and oncology therapeutic unit, Mariah Baltezegar, Vice President of Peri- and Post-Approval Study Innovation, and Tim Rich, Vice President of Consulting, Innovation, and Strategy for PPD Digital, to discuss the current state of oncology clinical trials in the wake of COVID-19, patient-centric concerns, and the evolution of decentralized oncology clinical trials.

How Can Oncology Trials Be Decentralized?

chat button